4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-007640
Options or other derivatives
- Senior VP - CMO acquired 22,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sheridan William P Senior VP - CMO | 2020-02-21 | Grant or award · Emp. Stock Option (Right to Buy) | +22,600 | 22,600 | D: show line 1 in the form |
Loading xslF345X03/form4.xml…